Dosidal · Switzerland

Noxafil, Suspension zum Einnehmen

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:57843 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 57843
atc: J02AC04
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2007-03-02
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: J02AC04
authorisation_number: 57843
form: SUOR
holder: MSD Merck Sharp & Dohme AG
holder_partner_nr: 1003060
it_number: 08.06.0.
name: Noxafil, Suspension zum Einnehmen
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
w51YEV_8OjMQXu_pzsMURupP5_G6vLDfEe3wATFe7J9nD6CJDHvWkr5nUTumX9x-AAkCf6vfwvQZHfDhKpuuoA
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:57843 · Same medicine in other markets · Dosidal